ION BEAM APPLICATIONS (IBAB.BR) Fundamental Analysis & Valuation

EBR:IBAB • BE0003766806

Current stock price

14.06 EUR
+0.76 (+5.71%)
Last:

This IBAB.BR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. IBAB.BR Profitability Analysis

1.1 Basic Checks

  • In the past year IBAB was profitable.
  • In the past year IBAB had a positive cash flow from operations.
  • IBAB had positive earnings in 4 of the past 5 years.
  • In multiple years IBAB reported negative operating cash flow during the last 5 years.
IBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFIBAB.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M

1.2 Ratios

  • IBAB has a Return On Assets (2.71%) which is comparable to the rest of the industry.
  • With an excellent Return On Equity value of 14.29%, IBAB belongs to the best of the industry, outperforming 80.95% of the companies in the same industry.
  • IBAB has a better Return On Invested Capital (16.28%) than 93.65% of its industry peers.
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROIC 16.28%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
IBAB.BR Yearly ROA, ROE, ROICIBAB.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 -20 -30

1.3 Margins

  • With a Profit Margin value of 2.85%, IBAB is not doing good in the industry: 61.90% of the companies in the same industry are doing better.
  • In the last couple of years the Profit Margin of IBAB has declined.
  • IBAB's Operating Margin of 6.48% is on the low side compared to the rest of the industry. IBAB is outperformed by 60.32% of its industry peers.
  • In the last couple of years the Operating Margin of IBAB has declined.
  • IBAB has a Gross Margin of 31.21%. This is amonst the worse of the industry: IBAB underperforms 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of IBAB has declined.
Industry RankSector Rank
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
IBAB.BR Yearly Profit, Operating, Gross MarginsIBAB.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. IBAB.BR Health Analysis

2.1 Basic Checks

  • IBAB has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • There is no outstanding debt for IBAB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
IBAB.BR Yearly Shares OutstandingIBAB.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
IBAB.BR Yearly Total Debt VS Total AssetsIBAB.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

  • IBAB has an Altman-Z score of 1.69. This is a bad value and indicates that IBAB is not financially healthy and even has some risk of bankruptcy.
  • IBAB has a Altman-Z score of 1.69. This is in the lower half of the industry: IBAB underperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that IBAB is not too dependend on debt financing.
  • Looking at the Debt to Equity ratio, with a value of 0.23, IBAB is in the better half of the industry, outperforming 68.25% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z 1.69
ROIC/WACC2.09
WACC7.78%
IBAB.BR Yearly LT Debt VS Equity VS FCFIBAB.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M 100M 150M

2.3 Liquidity

  • IBAB has a Current Ratio of 0.94. This is a bad value and indicates that IBAB is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 0.94, IBAB is doing worse than 84.13% of the companies in the same industry.
  • A Quick Ratio of 0.62 indicates that IBAB may have some problems paying its short term obligations.
  • The Quick ratio of IBAB (0.62) is worse than 80.95% of its industry peers.
Industry RankSector Rank
Current Ratio 0.94
Quick Ratio 0.62
IBAB.BR Yearly Current Assets VS Current LiabilitesIBAB.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. IBAB.BR Growth Analysis

3.1 Past

  • IBAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 41.86%, which is quite impressive.
  • The earnings per share for IBAB have been decreasing by -16.73% on average. This is quite bad
  • The Revenue has grown by 21.86% in the past year. This is a very strong growth!
  • IBAB shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 14.73% yearly.
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 35.60% on average over the next years. This is a very strong growth
  • IBAB is expected to show a decrease in Revenue. In the coming years, the Revenue will decrease by -0.86% yearly.
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
IBAB.BR Yearly Revenue VS EstimatesIBAB.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 200M 400M 600M
IBAB.BR Yearly EPS VS EstimatesIBAB.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 0.5 1

More info and screens

Find the best growth stocksShow best growing peers

5

4. IBAB.BR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 32.70, which means the current valuation is very expensive for IBAB.
  • The rest of the industry has a similar Price/Earnings ratio as IBAB.
  • IBAB's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.18.
  • A Price/Forward Earnings ratio of 13.58 indicates a correct valuation of IBAB.
  • Based on the Price/Forward Earnings ratio, IBAB is valued cheaply inside the industry as 82.54% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of IBAB to the average of the S&P500 Index (37.96), we can say IBAB is valued rather cheaply.
Industry RankSector Rank
PE 32.7
Fwd PE 13.58
IBAB.BR Price Earnings VS Forward Price EarningsIBAB.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IBAB indicates a rather cheap valuation: IBAB is cheaper than 84.13% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 9.01
IBAB.BR Per share dataIBAB.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

  • IBAB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • A more expensive valuation may be justified as IBAB's earnings are expected to grow with 35.60% in the coming years.
PEG (NY)0.41
PEG (5Y)N/A
EPS Next 2Y38.16%
EPS Next 3Y35.6%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

3

5. IBAB.BR Dividend Analysis

5.1 Amount

  • IBAB has a Yearly Dividend Yield of 1.36%. Purely for dividend investing, there may be better candidates out there.
  • IBAB's Dividend Yield is a higher than the industry average which is at 1.23.
  • Compared to the average S&P500 Dividend Yield of 1.82, IBAB is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.36%

5.2 History

Dividend Growth(5Y)N/A
Div Incr Years1
Div Non Decr Years1
IBAB.BR Yearly Dividends per shareIBAB.BR Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.05 0.1 0.15 0.2

5.3 Sustainability

  • IBAB pays out 8.05% of its income as dividend. This is a sustainable payout ratio.
DP8.05%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
IBAB.BR Yearly Income VS Free CF VS DividendIBAB.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M -50M
IBAB.BR Dividend Payout.IBAB.BR Dividend Payout, showing the Payout Ratio.IBAB.BR Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

IBAB.BR Fundamentals: All Metrics, Ratios and Statistics

ION BEAM APPLICATIONS

EBR:IBAB (4/14/2026, 5:29:46 PM)

14.06

+0.76 (+5.71%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-27
Earnings (Next)05-09
Inst Owners27.34%
Inst Owner ChangeN/A
Ins Owners0.71%
Ins Owner ChangeN/A
Market Cap425.74M
Revenue(TTM)620.22M
Net Income(TTM)17.00M
Analysts80
Price Target16.07 (14.3%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.36%
Yearly Dividend0.17
Dividend Growth(5Y)N/A
DP8.05%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)3.28%
PT rev (3m)9.88%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.22%
EPS NY rev (3m)-1.93%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.37%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 32.7
Fwd PE 13.58
P/S 0.71
P/FCF N/A
P/OCF 152.92
P/B 3.58
P/tB 4.51
EV/EBITDA 9.01
EPS(TTM)0.43
EY3.06%
EPS(NY)1.04
Fwd EY7.36%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.09
OCFY0.65%
SpS19.7
BVpS3.93
TBVpS3.12
PEG (NY)0.41
PEG (5Y)N/A
Graham Number6.17
Profitability
Industry RankSector Rank
ROA 2.71%
ROE 14.29%
ROCE 25.19%
ROIC 16.28%
ROICexc 17.24%
ROICexgc 20.74%
OM 6.48%
PM (TTM) 2.85%
GM 31.21%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y17.29%
OM growth 5Y-18.98%
PM growth 3Y6.89%
PM growth 5Y-27.51%
GM growth 3Y-2.84%
GM growth 5Y-5.9%
F-Score6
Asset Turnover0.95
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA 0.54
Cap/Depr 65.94%
Cap/Sales 1.38%
Interest Coverage 250
Cash Conversion 5.44%
Profit Quality N/A
Current Ratio 0.94
Quick Ratio 0.62
Altman-Z 1.69
F-Score6
WACC7.78%
ROIC/WACC2.09
Cap/Depr(3y)87.67%
Cap/Depr(5y)76.45%
Cap/Sales(3y)2.06%
Cap/Sales(5y)1.96%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)41.86%
EPS 3Y27.82%
EPS 5Y-16.73%
EPS Q2Q%-21.38%
EPS Next Y78.85%
EPS Next 2Y38.16%
EPS Next 3Y35.6%
EPS Next 5YN/A
Revenue 1Y (TTM)21.86%
Revenue growth 3Y19.74%
Revenue growth 5Y14.73%
Sales Q2Q%8.09%
Revenue Next Year3.13%
Revenue Next 2Y3.53%
Revenue Next 3Y3.47%
Revenue Next 5Y-0.86%
EBIT growth 1Y38.72%
EBIT growth 3Y40.44%
EBIT growth 5Y-7.05%
EBIT Next Year88.61%
EBIT Next 3Y37.43%
EBIT Next 5YN/A
FCF growth 1Y85.1%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y110.43%
OCF growth 3YN/A
OCF growth 5YN/A

ION BEAM APPLICATIONS / IBAB.BR Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ION BEAM APPLICATIONS?

ChartMill assigns a fundamental rating of 3 / 10 to IBAB.BR.


What is the valuation status of ION BEAM APPLICATIONS (IBAB.BR) stock?

ChartMill assigns a valuation rating of 5 / 10 to ION BEAM APPLICATIONS (IBAB.BR). This can be considered as Fairly Valued.


Can you provide the profitability details for ION BEAM APPLICATIONS?

ION BEAM APPLICATIONS (IBAB.BR) has a profitability rating of 3 / 10.


What is the earnings growth outlook for ION BEAM APPLICATIONS?

The Earnings per Share (EPS) of ION BEAM APPLICATIONS (IBAB.BR) is expected to grow by 78.85% in the next year.


How sustainable is the dividend of ION BEAM APPLICATIONS (IBAB.BR) stock?

The dividend rating of ION BEAM APPLICATIONS (IBAB.BR) is 3 / 10 and the dividend payout ratio is 8.05%.